Jean F. Voltaire

Array ( [id] => 4681775 [patent_doc_number] => 20080248001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/935655 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16959 [patent_no_of_claims] => 255 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248001.pdf [firstpage_image] =>[orig_patent_app_number] => 11935655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320567 [patent_doc_number] => 20100113392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHODS OF USING SAHA AND BORTEZOMIB FOR TREATING MULTIPLE MYELOMA' [patent_app_type] => utility [patent_app_number] => 12/312163 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20572 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113392.pdf [firstpage_image] =>[orig_patent_app_number] => 12312163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808174 [patent_doc_number] => 20080171752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => '5-HT1A Receptor Subtype Agonist' [patent_app_type] => utility [patent_app_number] => 11/932795 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4732 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171752.pdf [firstpage_image] =>[orig_patent_app_number] => 11932795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331356 [patent_doc_number] => 20090111833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Injectable meclizine formulations and methods' [patent_app_type] => utility [patent_app_number] => 11/980845 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6138 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111833.pdf [firstpage_image] =>[orig_patent_app_number] => 11980845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682953 [patent_doc_number] => 20080249179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Methods of treating cancer with HDAC inhibitors' [patent_app_type] => utility [patent_app_number] => 11/981500 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26064 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249179.pdf [firstpage_image] =>[orig_patent_app_number] => 11981500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823479 [patent_doc_number] => 20080227862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Methods of treating cancer with HDAC inhibitors' [patent_app_type] => utility [patent_app_number] => 11/980994 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26063 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227862.pdf [firstpage_image] =>[orig_patent_app_number] => 11980994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880470 [patent_doc_number] => 20080153853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'USE OF MTKI 1 FOR TREATING OR PREVENTING BRAIN CANCER' [patent_app_type] => utility [patent_app_number] => 11/875350 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5837 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153853.pdf [firstpage_image] =>[orig_patent_app_number] => 11875350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204829 [patent_doc_number] => 07629352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Pharmaceutical composition comprising a corticosteroid and a specific inhibitor of hedgehog/smoothened signaling' [patent_app_type] => utility [patent_app_number] => 11/874653 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 52 [patent_no_of_words] => 9101 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629352.pdf [firstpage_image] =>[orig_patent_app_number] => 11874653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698884 [patent_doc_number] => 20080221068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'ANTI-TUMOR AGENTS' [patent_app_type] => utility [patent_app_number] => 11/872371 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18700 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221068.pdf [firstpage_image] =>[orig_patent_app_number] => 11872371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249449 [patent_doc_number] => 20100137419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'ANTI-CANCER AGENT' [patent_app_type] => utility [patent_app_number] => 12/445461 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3122 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137419.pdf [firstpage_image] =>[orig_patent_app_number] => 12445461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452070 [patent_doc_number] => 20090068107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'ENZYME REGULATING ETHER LIPID SIGNALING PATHWAYS' [patent_app_type] => utility [patent_app_number] => 11/866349 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14553 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068107.pdf [firstpage_image] =>[orig_patent_app_number] => 11866349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846457 [patent_doc_number] => 20080182865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'HISTONE DEACETYLASE INHIBITORS SENSITIZE CANCER CELLS TO EPIDERMAL GROWTH FACTOR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/861033 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 33455 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182865.pdf [firstpage_image] =>[orig_patent_app_number] => 11861033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4826870 [patent_doc_number] => 20080125414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Method of Treatment' [patent_app_type] => utility [patent_app_number] => 11/852727 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3175 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125414.pdf [firstpage_image] =>[orig_patent_app_number] => 11852727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693140 [patent_doc_number] => 20080085911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS' [patent_app_type] => utility [patent_app_number] => 11/851867 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10286 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085911.pdf [firstpage_image] =>[orig_patent_app_number] => 11851867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495324 [patent_doc_number] => 20100010002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'ANTICANCER USE OF CAFFEIC ACID AND ITS DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/439587 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13729 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010002.pdf [firstpage_image] =>[orig_patent_app_number] => 12439587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771466 [patent_doc_number] => 20080057124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties' [patent_app_type] => utility [patent_app_number] => 11/894729 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3017 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057124.pdf [firstpage_image] =>[orig_patent_app_number] => 11894729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729965 [patent_doc_number] => 08101660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer' [patent_app_type] => utility [patent_app_number] => 11/839522 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20071 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101660.pdf [firstpage_image] =>[orig_patent_app_number] => 11839522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234886 [patent_doc_number] => 20100266590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/309665 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16375 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266590.pdf [firstpage_image] =>[orig_patent_app_number] => 12309665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651007 [patent_doc_number] => 20080038263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas' [patent_app_type] => utility [patent_app_number] => 11/888881 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12062 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038263.pdf [firstpage_image] =>[orig_patent_app_number] => 11888881 [rel_patent_id] =>[rel_patent_doc_number] =>)